Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 8-K Event Shareholder vote results
  2. DEFA14A Proxy Proxy Materials
  3. DEFA14A Proxy Proxy Materials
  4. 8-K Event Regulation FD disclosure
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. DEF 14A Proxy Proxy Statement
  8. 8-K Event Regulation FD disclosure
  9. 10-Q/A Report 10-Q/A
  10. 8-K Event Director nominations
  11. 10-Q Report Quarterly Report
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 31 · 604 filings